Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

BACKGROUND: Radium-223 chloride ((223)Ra; Alpharadin) is an alpha-emitting radioisotope that targets areas of osteoblastic metastasis and is excreted by the small intestine. When compared with beta-emitters (eg, strontium-89, samarium-153), (223)Ra delivers a high quantity of energy per track length...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Michael R, Wong, Terence Z, Armstrong, Andrew J, George, Daniel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544343/
https://www.ncbi.nlm.nih.gov/pubmed/23326203
http://dx.doi.org/10.2147/CMAR.S25537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544343/
https://www.ncbi.nlm.nih.gov/pubmed/23326203
http://dx.doi.org/10.2147/CMAR.S25537

Ejemplares similares